Skip to main content
. Author manuscript; available in PMC: 2011 Feb 7.
Published in final edited form as: Am J Physiol Renal Physiol. 2006 Oct 17;292(3):F1044–F1053. doi: 10.1152/ajprenal.00175.2006

Table 2.

Drug effects on tonic and bursting EUS activity (area, mV-ms) during bladder filling or voiding in rats with intact-SC and chronic SCT at T8 –9 and L3– 4

Intact-SC (n = 10)
Chronic T8–9 SCT (n = 6)
Chronic L3–4 SCT (n = 7)
Tonic Activity During Filling EUS Bursting During Voiding Tonic Activity During Filling EUS Activity During Voiding Tonic Activity During Filling Tonic Activity During Voiding
Before drugs 21.4±0.6 98.1±2.6 16.2±0.1 77.7±1.5(a) 14.6±0.5 49.2±0.2
8-OH-DPAT 43.7±1.2* 165.4±4.1* 36.1±1.1*(d) 122.6±3.8* (b, d) 37.4±0.9* 119.4±2.6*
WAY100635 18.9±0.4† 95.6±1.9† 20.3±0.5† (d) 88.7±7.3† (c, d) 19.3±0.4† 72.6±3.9*†

Values are means ± SE. EUS, external urethral sphincter.

(a)

EUS tonic activity (n = 4) and EUS bursting activity (n = 2).

(b)

EUS bursting activity.

(c)

EUS tonic activity.

(d)

Drugs were tested in 5 of the chronic T8–9 SCT rats.

*

P < 0.05, significantly increased compared with control before drugs.

†

P < 0.05, significantly reduced compared with records after 8-OH-DPAT.